GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS)
CNY 19.33
(1.52%)
CNY 19.33
(1.52%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.28 Billion CNY | 29.09% |
| 2022 | 994.69 Million CNY | 16.44% |
| 2021 | 854.22 Million CNY | -23.0% |
| 2020 | 1.1 Billion CNY | -8.85% |
| 2019 | 1.21 Billion CNY | -24.81% |
| 2018 | 1.61 Billion CNY | 38.51% |
| 2017 | 1.16 Billion CNY | 24.73% |
| 2016 | 936.99 Million CNY | 118.7% |
| 2015 | 428.43 Million CNY | 20.97% |
| 2014 | 354.15 Million CNY | 32.09% |
| 2013 | 268.11 Million CNY | 2.86% |
| 2012 | 260.65 Million CNY | 13.86% |
| 2011 | 228.92 Million CNY | -0.39% |
| 2010 | 229.82 Million CNY | -10.8% |
| 2009 | 257.64 Million CNY | -16.28% |
| 2008 | 307.72 Million CNY | -42.07% |
| 2007 | 531.19 Million CNY | -1.7% |
| 2006 | 540.37 Million CNY | -1.61% |
| 2005 | 549.2 Million CNY | -2.52% |
| 2004 | 563.37 Million CNY | 0.7% |
| 2003 | 559.45 Million CNY | 10.94% |
| 2002 | 504.3 Million CNY | 13.15% |
| 2001 | 445.67 Million CNY | 43.29% |
| 2000 | 311.03 Million CNY | 31.13% |
| 1999 | 237.2 Million CNY | 81.94% |
| 1998 | 130.36 Million CNY | 7.03% |
| 1997 | 121.8 Million CNY | 46.53% |
| 1996 | 83.12 Million CNY | 14.85% |
| 1995 | 72.37 Million CNY | 142.76% |
| 1994 | 29.81 Million CNY | 55.53% |
| 1993 | 19.17 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 311.85 Million CNY | -9.18% |
| 2024 Q1 | 343.37 Million CNY | 9.52% |
| 2024 Q3 | 233.92 Million CNY | -24.99% |
| 2023 Q4 | 313.54 Million CNY | 14.45% |
| 2023 Q1 | 369.04 Million CNY | 112.84% |
| 2023 FY | 1.28 Billion CNY | 29.09% |
| 2023 Q2 | 294.8 Million CNY | -20.12% |
| 2023 Q3 | 273.95 Million CNY | -7.07% |
| 2022 Q3 | 341.88 Million CNY | 41.53% |
| 2022 Q2 | 241.56 Million CNY | 1.56% |
| 2022 Q1 | 237.84 Million CNY | -8.33% |
| 2022 Q4 | 173.39 Million CNY | -49.28% |
| 2022 FY | 994.69 Million CNY | 16.44% |
| 2021 Q4 | 259.46 Million CNY | 18.27% |
| 2021 Q1 | 190.02 Million CNY | -55.02% |
| 2021 Q3 | 219.38 Million CNY | 18.36% |
| 2021 FY | 854.22 Million CNY | -23.0% |
| 2021 Q2 | 185.35 Million CNY | -2.46% |
| 2020 Q3 | 254.38 Million CNY | 22.51% |
| 2020 FY | 1.1 Billion CNY | -8.85% |
| 2020 Q1 | 224.9 Million CNY | -38.03% |
| 2020 Q2 | 207.65 Million CNY | -7.67% |
| 2020 Q4 | 422.48 Million CNY | 66.08% |
| 2019 FY | 1.21 Billion CNY | -24.81% |
| 2019 Q1 | 271.31 Million CNY | -54.56% |
| 2019 Q2 | 270.09 Million CNY | -0.45% |
| 2019 Q4 | 362.93 Million CNY | 16.05% |
| 2019 Q3 | 312.74 Million CNY | 15.79% |
| 2018 Q4 | 597.14 Million CNY | 62.9% |
| 2018 Q2 | 361.54 Million CNY | 23.18% |
| 2018 FY | 1.61 Billion CNY | 38.51% |
| 2018 Q1 | 293.5 Million CNY | -31.89% |
| 2018 Q3 | 366.57 Million CNY | 1.39% |
| 2017 FY | 1.16 Billion CNY | 24.73% |
| 2017 Q4 | 430.92 Million CNY | 84.13% |
| 2017 Q3 | 234.03 Million CNY | -22.54% |
| 2017 Q2 | 302.14 Million CNY | 49.89% |
| 2017 Q1 | 201.57 Million CNY | -36.35% |
| 2016 Q3 | 223.49 Million CNY | 7.85% |
| 2016 Q2 | 207.22 Million CNY | 9.3% |
| 2016 Q4 | 316.69 Million CNY | 41.7% |
| 2016 Q1 | 189.58 Million CNY | 24.33% |
| 2016 FY | 936.99 Million CNY | 118.7% |
| 2015 FY | 428.43 Million CNY | 20.97% |
| 2015 Q2 | 119.06 Million CNY | 41.31% |
| 2015 Q4 | 152.48 Million CNY | 109.93% |
| 2015 Q3 | 72.63 Million CNY | -38.99% |
| 2015 Q1 | 84.25 Million CNY | -9.91% |
| 2014 Q2 | 103.91 Million CNY | 78.71% |
| 2014 Q1 | 58.15 Million CNY | -27.49% |
| 2014 FY | 354.15 Million CNY | 32.09% |
| 2014 Q4 | 93.51 Million CNY | -5.12% |
| 2014 Q3 | 98.56 Million CNY | -5.15% |
| 2013 Q4 | 80.2 Million CNY | 38.99% |
| 2013 FY | 268.11 Million CNY | 2.86% |
| 2013 Q3 | 57.7 Million CNY | -1.23% |
| 2013 Q2 | 58.42 Million CNY | -18.61% |
| 2013 Q1 | 71.78 Million CNY | 20.34% |
| 2012 FY | 260.65 Million CNY | 13.86% |
| 2012 Q2 | 63.64 Million CNY | -0.99% |
| 2012 Q3 | 73.06 Million CNY | 14.8% |
| 2012 Q4 | 59.64 Million CNY | -18.37% |
| 2012 Q1 | 64.28 Million CNY | 46.32% |
| 2011 Q2 | 71.08 Million CNY | 30.66% |
| 2011 Q1 | 54.4 Million CNY | -6.5% |
| 2011 Q3 | 59.49 Million CNY | -16.31% |
| 2011 Q4 | 43.93 Million CNY | -26.15% |
| 2011 FY | 228.92 Million CNY | -0.39% |
| 2010 Q1 | 62.98 Million CNY | 14.97% |
| 2010 Q2 | 56.62 Million CNY | -10.1% |
| 2010 Q3 | 52.02 Million CNY | -8.13% |
| 2010 Q4 | 58.19 Million CNY | 11.87% |
| 2010 FY | 229.82 Million CNY | -10.8% |
| 2009 FY | 257.64 Million CNY | -16.28% |
| 2009 Q1 | 82.23 Million CNY | 921.95% |
| 2009 Q2 | 65.95 Million CNY | -19.8% |
| 2009 Q3 | 54.67 Million CNY | -17.1% |
| 2009 Q4 | 54.78 Million CNY | 0.19% |
| 2008 Q3 | 57.1 Million CNY | -62.45% |
| 2008 Q4 | -10 Million CNY | -117.52% |
| 2008 Q2 | 152.07 Million CNY | 40.11% |
| 2008 Q1 | 108.54 Million CNY | -48.97% |
| 2008 FY | 307.72 Million CNY | -42.07% |
| 2007 FY | 531.19 Million CNY | -1.7% |
| 2007 Q2 | 59.35 Million CNY | -61.05% |
| 2007 Q1 | 152.41 Million CNY | -13.07% |
| 2007 Q3 | 106.72 Million CNY | 79.79% |
| 2007 Q4 | 212.69 Million CNY | 99.29% |
| 2006 Q1 | 159.4 Million CNY | -10.47% |
| 2006 Q4 | 175.32 Million CNY | 117.93% |
| 2006 Q3 | 80.45 Million CNY | -35.74% |
| 2006 Q2 | 125.18 Million CNY | -21.47% |
| 2006 FY | 540.37 Million CNY | -1.61% |
| 2005 Q2 | 82.5 Million CNY | -46.8% |
| 2005 FY | 549.2 Million CNY | -2.52% |
| 2005 Q1 | 155.08 Million CNY | 1.45% |
| 2005 Q3 | 133.55 Million CNY | 61.88% |
| 2005 Q4 | 178.06 Million CNY | 33.33% |
| 2004 Q2 | 109.14 Million CNY | -39.01% |
| 2004 Q1 | 178.95 Million CNY | -0.13% |
| 2004 FY | 563.37 Million CNY | 0.7% |
| 2004 Q4 | 152.87 Million CNY | 24.9% |
| 2004 Q3 | 122.39 Million CNY | 12.14% |
| 2003 Q2 | 111.74 Million CNY | -21.79% |
| 2003 FY | 559.45 Million CNY | 10.94% |
| 2003 Q1 | 142.87 Million CNY | -19.44% |
| 2003 Q4 | 179.18 Million CNY | 42.6% |
| 2003 Q3 | 125.65 Million CNY | 12.45% |
| 2002 Q2 | 104.46 Million CNY | -8.97% |
| 2002 FY | 504.3 Million CNY | 13.15% |
| 2002 Q3 | 107.72 Million CNY | 3.12% |
| 2002 Q4 | 177.34 Million CNY | 64.62% |
| 2002 Q1 | 114.76 Million CNY | 0.0% |
| 2001 FY | 445.67 Million CNY | 43.29% |
| 2000 FY | 311.03 Million CNY | 31.13% |
| 1999 FY | 237.2 Million CNY | 81.94% |
| 1998 FY | 130.36 Million CNY | 7.03% |
| 1997 FY | 121.8 Million CNY | 46.53% |
| 1996 FY | 83.12 Million CNY | 14.85% |
| 1995 FY | 72.37 Million CNY | 142.76% |
| 1994 FY | 29.81 Million CNY | 55.53% |
| 1993 FY | 19.17 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 22.81 Billion CNY | 94.373% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 10.05 Billion CNY | 87.235% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 6.73 Billion CNY | 80.929% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 2.31 Billion CNY | 44.46% |
| Aurora Optoelectronics Co.,Ltd. | 327.9 Million CNY | -291.577% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 121.77 Million CNY | -954.386% |
| NanJing Pharmaceutical Company Limited | 53.58 Billion CNY | 97.604% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 3.07 Billion CNY | 58.249% |